Pranidipine

CAS No. 99522-79-9

Pranidipine( OPC-13340 )

Catalog No. M26794 CAS No. 99522-79-9

Pranidipine is a novel, long-acting 1,4-dihydropyridine calcium channel blocker.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 72 Get Quote
10MG 125 Get Quote
25MG 250 Get Quote
50MG 430 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Pranidipine
  • Note
    Research use only, not for human use.
  • Brief Description
    Pranidipine is a novel, long-acting 1,4-dihydropyridine calcium channel blocker.
  • Description
    Pranidipine is a novel, long-acting 1,4-dihydropyridine calcium channel blocker. It prolongs acetylcholine-induced relaxation in presence of endothelium as well as nitroglycerin-induced relaxation in absence of endothelium. It also has antihypertensive activity.(In Vivo):Pranidipine enhances cyclic GMP-dependent nitric oxide-induced relaxation of rat aorta.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    OPC-13340
  • Pathway
    GPCR/G Protein
  • Target
    Calcium Channel
  • Recptor
    Autophagy| mTORC1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    99522-79-9
  • Formula Weight
    448.475
  • Molecular Formula
    C25H24N2O6
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 270 mg/mL (602.05 mM)
  • SMILES
    COC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC\C=C\c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Laraia L, et al. The cholesterol transfer protein GRAMD1A regulates autophagosome biogenesis. Nat Chem Biol. 2019 Jul;15(7):710-720.
molnova catalog
related products
  • MRS1845

    MRS1845 is an ORAI1 inhibitor and calcium entry (SOCE) blocker that blocks VP-induced SOCE, OS, and Ca(2+) deposition.

  • Flosatidil

    Flosatidil is a small molecule voltage-gated calcium channel complex (VDCCs) blocker for the treatment of neurological disorders and cardiovascular diseases, and can be used in the study of angina pectoris.

  • ω-Agatoxin TK

    Selective blocker of CaV2.1 P/Q-type calcium channels.